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S U M M A R Y 
The action of Sendai virus specific cytolytic Τ lymphocytes (CTL) against Sen-
dai virus infected macrophages was found to be H -2 restricted while Sendai 
virus infected cell lines, including fibroblasts and tumour cells, were lysed across 
the H -2 barrier to some extent. The properties of the Meth-A tumour cell, which 
was resistant to lysis by allogenic killer cells was investigated. Sendai virus 
specific CTL failed to kill Sendai virus infected Meth-A cells but after vaccinia 
virus infection these target cells were susceptible to lysis by vaccinia virus 
specific CTL. 
I N T R O D U C T I O N 
Mice injected with L C M virus, poxviruses or a parainfluenza virus (Sendai) generate virus 
specific effector lymphocytes (Zinkernagel & Doherty, 1974; Gardner et al, 1975; 
Koszinowski & Thomssen, 1975; Ertl & Koszinowski, 1976). These effector cells lyse in­
fected target cells in vitro. The active cell population in these reactions could be identified 
as T-cells. It was observed first by Zinkernagel & Doherty (1974) in the L C M virus system 
that the effector cells, sensitized to a virus, need for a cytolytic interaction with the infec­
ted target cells a compatibility of Κ or D region gene products. This specific property of 
the virus specific cytolytic T-cells (CTL) drew attention to a possible physiological func­
tion of the major histocompatibility complex in cellular immune surveillance against cells 
bearing neoantigens on the cell surface. For the explanation of the restriction of cell 
mediated cytolysis to H - 2 compatibility two hypotheses have been formulated (Doherty & 
Zinkernagel, 1975). Firstly the T-cells need for recognition and specific lysis the contact 
with two antigenic determinants, a self antigen and a viral antigen. The second is, that the 
virus modifies, in a way unknown at present, the antigenic product of the Κ or D region, 
this new antigen is recognized by the T-cells. Recent findings in chimeric mice suggest 
* Presented at symposium: 'Histocompatibility gene products in normal neoplastic and virus infected cells', 
Hruba Scala, April 1976. 
Abbreviations: C T L , cytolytic T lymphocytes; C M C , cell mediated cytolysis; E I D 5 0 , 50% egg infective 
dose; L C M , lymphocytic choriomeningitis; L D 5 0 , 50% lethal dose; M E M , minimal essential medium; T-cell, 
Thymus derived cell. 
Correspondence: Dr U. Koszinowski, Tumour Immunology Unit, Zoology Department, University College, 
Gower Street, London W C I E 6BJ, England. 
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(Pfizenmaier et al, 1976), that the second theory, the 'altered self concept seems to be 
more likely, since modifications of allogenic cells can also be recognized, provided the T-
cell is tolerant to these antigens. 
M A T E R I A L S A N D M E T H O D S 
Viruses 
Sendai virus. Strain D-52 (Behringwerke A G , Marburg/Lahn) was propagated in the 
allantoic fluid of 10-day-old fertile eggs. The twenty-seventh passage was used throughout. 
The virus was diluted to a titre of 107 E ID 5 0 /ml . 
Vaccinia virus. Strain WR was propagated in Vero (African green monkey kidney) or in 
OMK (owl monkey kidney) cells and diluted to a titre of 10 5 · 5 TCID 5 0 /m l . 
LCM virus. Strain WE-3 kindly provided by Dr Lehmann-Grube, Hamburg, was 
propagated in L-929 cells and used in a concentration of 300 L D 5 0 / m l . 
Mice 
Inbred mice o f strains C3H (H-2 k), DBA-2 (H-2 d) and C57B1/6 (H-2 b) purchased from 
B. L. Bomholdgard, Ry, Denmark, were used at the age o f 8-12 weeks. 
Indirect immunofluorescence 
Indirect immunofluorescence of viral surface antigens on viable infected cells was per­
formed as described earlier (Koszinowski & Ertl, 1975). 
Target cells 
L-929 cells (H-2k) were grown as monolayers in Eagle's minimal essential medium sup­
plemented with 10% calf serum and 100//g/ml penicillin and streptomycin. Mastocytoma 
P-815 (H-2 d), Meth-A (H-2 d), SL-2 (Η-2*) and EL-4 (H-2 b) tumour cells, kindly provided by 
Dr Festenstein, London, were passaged in the peritoneal cavity of syngeneic mice. These 
tumour lines were maintained in vitro as suspension cultures in Eagle's minimal essential 
medium supplemented with 10% fetal calf serum, 200 m M glutamine, 1% non-essential 
amino acids and 100 //g/ml penicillin and streptomycin. Macrophages were harvested 3 
days after i.p. injection of 2 ml thioglycolate and separated from other cells by affinity to 
glass or plastic surfaces and trypsin resistance. 
Infection of target cells 
A volume of 5 ml virus suspension (about 5 infective units/cell) was added to 1 χ 106 L-
929 monolayer cells. One hour later the medium containing virus was discarded and fresh 
medium was added. Tumour cells, 1-5 χ 106, were suspended in medium containing virus 
for 1 hr, centrifuged and then resuspended in fresh medium. Macrophages were cultivated 
for 4 hr in petri dishes. The non-adherent cells were removed and virus was added. After 
1 hr incubation the virus containing fluid was replaced by fresh medium. Efficiency of in­
fection was monitored 10 hr later by indirect immunofluorescence. 
Sensitization to alloantigens 
Mitomycin C treated stimulator cells, 1 χ 106, were incubated with 4 χ 106 responder 
spleen cells in 2 ml Dulbecco's modified medium supplemented with 5% FCS and 
100/zg/ml penicillin and streptomycin in a C 0 2 atmosphere at 37°C. As stimulator cells 
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spleen cells or tumour cells from different inbred strains were used. The cells were har­
vested 5 or 6 days later and their activity on the appropriate 51Cr-labelled target cells was 
tested in a 6-10 hr assay. Ratio of attacker to target cells ranged between 20:1 and 50:1 . 
Cytotoxic assay 
The assay was performed with some modifications according to the method of Wagner 
(1973). The amount of 1-5 χ 104, about 6-14 hr infected or not infected 51Cr-labelled 
target cells, were incubated with 1-5 χ 106 lymphocytes from normal mice or mice sen­
sitized to virus 6 days previously, in a volume of 1 0 ml in 1 χ 5 cm round bottom plastic 
tubes. Spontaneous lysis was determined by adding medium instead of lymphocytes, the 
maximal lysis was determined by adding 1 Μ HCl to the target cells. After 8-18 hr incuba­
tion supernatant and cells were harvested separately. The percentage 51Cr-release was 
calculated using the formula: 
~ , t counts in the supernatant 1 Λ Λ Percentage 5 1 Cr-release = . . . — ^ — τ τ τ — χ 100. 
counts in the supernatant + in the pellet 
Specific lysis was calculated by subtraction of percentage 51Cr-release in presence of nor­
mal lymphocytes from percentage 51Cr-release in the presence of immune lymphocytes. 
Assays were done at least in triplicate, s.d. values of the data presented here were less than 
5%. Significance was calculated using the Student's Mest. 
Cold cell inhibition assay 
The assay was performed according to the method of Herbermann et ah (1976). Inhibi­
tion was calculated as follows: 
% specific lysis in _ % specific lysis in 
Percentage inhibition = immune control presence of inhibitory cells χ m 
of specific lysis % specific lysis in immune control 
Inhibitory cells were added in different ratios varying from 2:1 to 50:1 cold inhibitory 
cells to labelled target cells. 
R E S U L T S 
Virus specificity of cell mediated cytolysis 
Mice from the inbred strain C3H were injected intraperitoneally with either 10 5 , 5 
T C I D 5 0 vaccinia virus, 107 E I D 5 0 Sendai virus or 300 L D 5 0 L C M virus. Spleen cells were 
harvested 7 days later. Cytolytic activity was tested on macrophage targets infected with 
the sensitizing viruses. Lymphocyte activity was restricted to the virus according to which 
the lymphocyte donors were sensitized to (Table 1). Cross-reactivity could not be obser­
ved. Restriction of activity to the sensitizing virus reflects the antigenic specificity of the 
new determinant induced by the viral infection on the cell surface. 
H-2 gene restricted activity of CL on infected macrophages 
Sendai virus specific sensitized cells from C3H (H-2 k), DBA/2 (H-2 d) and C57B1/6 (H-
2b) mice were incubated with normal and Sendai virus infected macrophages bearing each 
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T A B L E 1. Virus specificity of T-cell mediated cytolysis 
Percentage specific cytolysis* 
Vaccinia 
sensitized 
Sendai 
sensitized L C M sensitized 
Target cells C 3 H lymphocytes C 3 H lymphocytes C 3 H lymphocytes 
Normal macrophages 0-2 + 0-3 0-7 ± 0 - 5 -3-3 ± 0 - 3 
Macrophages, infected 
with vaccinia virus 
36-9 ± 0 - 2 7-8 ± 0 - 9 5-3 ± 0 - 5 
Macrophages, infected 
with Sendai virus 
11 ± 0-6 42-2 ± 1-4 1-7 + 0 1 
Macrophages, infected 
with L C M virus 
-0 -4 ± 0 - 7 -1 -5 ± 0 1 27-4 ± 0 - 7 
* The activity of C 3 H spleen cells of mice sensitized 6 days previously was tested in a 8 hr 5 1Cr-release 
assay on target cells at a ratio effector cells: target cells = 100:1. 
of the three haplotypes. The effector cells killed only syngeneic infected target cells (Table 
2). 
Lysis of allogenic infected target cells 
The same sensitizing procedure was performed as in the preceding experiment. Sendai 
virus infected L-929 as well as infected tumour cells (P-815, Meth-A, EL-4) were used as 
targets in this experiment. In contrast to the results found with macrophage targets, cross 
killing of allogenic H-2 incompatible target cells could be observed. 
T A B L E 2. H-2 dependency of T-cell mediated cytolysis. Differences 
between primary cells and permanent cell lines 
Percentage specific lysis from target 
cells infected with Sendai virus 
Effector cells 
Target cells C 3 H D B A / 2 C57B1/6 
C 3 H macrophages 18 8 - 1 - 2 0-8 
L-929 30-8 11-6 9-9 
DBA/2 macrophages -6 -8 20-5 2-6 
P-815 6-9 16 9 1-7 
C57B1/6 macrophages 0 1 0-4 12-6 
EL-4 - 1 1 180 2 5 0 
Ratio of attacker cells to target cells 50:1. Incubation time 12 hr. 
Data represent the mean of four wells per group. Differences are 
statistically significant (P < 0 01). 
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Cytolytic interactions with Meth-Λ target cells 
In experiments with Sendai virus infected Meth-A cells this target was not killed by the 
effector cells. Virus specific immunofluorescence showed that this cell could be infected 
with Sendai virus. We therefore tested to see i f this target cell was resistant to lysis by 
allogenic killer cells. Allogenic lymphocytes were sensitized in vitro to H-2 d by incubation 
with mitomycin C treated DBA/2 cells. These effector cells were unable to lyse Meth-A 
cells, despite the fact that they lysed the H-2 d tumours P-815 and SL-2 (Table 3) very well. 
In a second approach we tested the possibility of sensitizing lymphocytes directly to Meth-
A cells in vitro. Cultures were set up with P-815, SL-2 and Meth-A as mitomycin C treated 
stimulator cells and C3H (H-2k) lymphocytes as responder cells. After 5 days there was a 
specific cytolytic response to P-815 and SL-2 but no response at all to Meth-A (Table 3). 
Treatment o f stimulator Meth-A with Vibrio cholerae neuraminidase had no increasing ef­
fect. 
Since Meth-A expresses H-2 d SD antigens we tested to see i f these cells could inhibit the 
cytolytic interaction between anti H-2 d killer cells and P-815 as targets. There was a clear 
dose-response relationship between the numbers of inhibitor cells in the test and inhibition, 
when tumour cells, bearing H-2 d were used as cold inhibitory cells. The slope of the inhibi­
tion curve after adding Meth-A cells was similar to that produced by the positive P-815 in­
hibition control. This shows that the antigenic determinants recognized on P-815 cells by 
anti H-2 d specific CTL are present on the Meth-A tumour cells as well (Fig. 1). The 
allogenic control cell EL-4 did not inhibit the cytolytic interaction. 
T A B L E 3. Behaviour of Meth-A tumour cells as stimulator and target cells 
Effector phase Percentage 
Sensitization (target cells) specific lysis 
H-2 k —• H-2 d lymphocytes P-815 61-7 
SL-2 58-3 
Meth-A 0-8 
H-2 k - > P-815 P-815 65-8 
SL-2 59-7 
H-2 k - > SL-2 P-815 63-3 
SL-2 62-5 
H-2 k Meth-A P-815 1-2 
SL-2 0-8 
Meth-A 0-4 
H-2 d —• Sendai virus P-815 Sendai virus 30-2 
infected 
Meth-A Sendai virus 2-4 
infected 
H-2 d —• Vaccinia virus P-815 Vaccinia virus 28-6 
infected 
Meth-A Sendai virus 26-5 
infected 
Allogenic lysis: ratio of effector cells to target cells 20:1; incubation 
time 6 hr. 
Virus specific lysis: ratio of effector cells to target cells 50:1; incubation 
time 12 hr. 
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FIG. 1. Percentage inhibition of cytolytic activity of C 3 H anti H-2 d killer cells towards 1 χ 104 
5 1Cr-labelled P-815 cells obtained with different numbers of cold E L - 4 ( · — · ) , P-815 ( • — • ) , 
SL-2 (O—O) or Meth-A ( • — • ) tumour cells. 
Ratio of attacker: 51Cr-labelled target cells 20:1. Incubation time 8 h; control cytolysis 
without inhibitory cells added was 48%. 
However, Meth-A cells were not always resistant to cell mediated cytolysis. When we in­
fected this cell with vaccinia virus it could be very well lysed by syngeneic effector cells 
sensitized to vaccinia virus (Table 3). 
D I S C U S S I O N 
Cell mediated specific lysis of targets modified by viral infections (Zinkernagel & Doherty, 
1974; Gardner et αϊ, 1975; Koszinowski & Thomssen, 1975; Ertl & Koszinowski, 1976), 
tumour antigens (Schräder & Edelman, 1976), chemical agents (Shearer, 1974), the male 
histocompatibility antigen of the mouse (Gordon et ah, 1975) and minor histo-
compatibility antigens (Bevan, 1975) is restricted to Κ or D compatibility between target 
and effector cell. Data presented here show the same restrictions in the Sendai virus infec­
tion when primary cells were used as targets. 
Using virus infected tumour cell lines as target cells different patterns of reactivity were 
observed. To some degree there was killing o f non-infected tumour target ceils. Infected 
target cells were specifically lysed across the H-2 barrier. One of the target cells could be 
lysed after infection with vaccinia but not with Sendai virus. 
Cross-reactivities could be due to different mechanisms. Firstly, some non-specific lysis 
may be caused by higher spontaneous lysis o f tumour cells infected with virus. Very active 
CTL can lyse target cells bearing modifications they are not sensitized to (Star-
zinski-Powitz et αϊ, 1976). The activity o f killer cells without specificity has to be 
excluded. The fact that the reactivity across the H-2 barrier was specific for the 'modifying' 
virus argues for an effector cell specificity since cells infected with unrelated viruses were 
not lysed (unpublished results). 
Similar cross-reactivities were seen when TNP modified tumour cell were used as targets 
for TNP specific CTL (Shearer et al, 1975). Sendai virus specific CTL induced in DBA/2 
Tumour cells and virus specific CMC 113 
( H - ^ mice killed infected EL-4 targets. The same activities were obtained in cross killing 
experiments with CTL from mice sensitized to H-2 d tumours (Schräder & Edelmann, 
1976). This means that CTL recognize antigenic determinants on tumours, which are not 
identical to the modified antigenic products of Κ or D region these cells should normally 
express. Possible explanations are activation of endogenous viruses, recognition of 
derepressed antigens (Bodmer, 1972) or of antigens not identical with private H-2 
specificities (Nabholz et al, 1974). Cross-reactivities against similar H-2 structures (Henn­
ing et α/., 1975) seem unlikely since virus specific CTL can even discriminate 'point' muta­
tions in the Κ region (Doherty et al., 1976). 
The observation that Meth-A cells neither sensitize allogenic cells in vitro nor are they 
susceptible to cytolysis by allogenic killer cells seems to indicate deficiencies of antigenic 
expressions of the H-2 complex on these cells. 
Since these antigens can be demonstrated by serological means (Garrido et al, 1976b) 
one could argue that these antigens are not accessible to the T-cell receptors. But positive 
recognition was found in the cold cell inhibition experiments. This suggests an inhibition of 
the lethal hit (Golstein & Smith, 1976). After vaccinia virus infection, virus specific CMC 
is possible. Similar results were found by Matossian-Rogers and coworkers (personal 
communication). This is not due to cytophatic effects of the virus itself as no lysis was 
obtained after Sendai infection. Therefore activities of vaccinia virus on membrane proper­
ties by rearrangement of surface structures or by removal of components interfering with 
T-cell mediated lysis could explain these data. 
In most of these experiments fibroblasts or macrophages served as targets for virus 
specific lysis. It has recently been shown, that tumour cells show immunological cross-
reactivities with alloantigens (Invernizzi & Parmiani, 1975; Bowen & Baldwin, 1975). By 
serological means expressions of new antigens on tumour cells have been found (Pellegrino 
et al, 1976; Garrido et al, 1976a, b). To summarize: in this paper we present preliminary 
data about virus specific reactions against infected tumour cells. When tumour cells were 
used as targets cross-reactivities with allogenic infected target cells could be observed. A 
tumour target cell of H-2 d haplotype resistant to lysis by allogenic anti H-2 d killer cells, but 
as susceptible as a vaccinia virus infected target cell to lysis by virus sensitized effector 
cells is described. 
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